Kenneth Mills

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kenneth Mills

Kenneth Mills is recorded as Board Member at REGENXBIO Inc. (RGNX). REGENXBIO Inc. reported in an 8-K filed June 13, 2024 that Kenneth Mills resigned as President and Chief Executive Officer, effective July 1, 2024. The proxy statement of REGENXBIO Inc. reports total compensation of $5,507,038 for Kenneth Mills in fiscal 2024, including a base salary of $340,998. Disclosed compensation is on record for 7 fiscal years. Kenneth Mills has spoken on 1 investor event across 1 company, most recently for REGENXBIO Inc. on September 15, 2026.

“On June 12, 2024, REGENXBIO Inc. (the "Company") announced that its Board of Directors (the "Board") accepted the resignation of Kenneth T. Mills from his position as President and Chief Executive Officer of the Company, effective July 1, 2024.”

REGENXBIO Inc. Form 8-K, filed June 13, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

REGENXBIO Inc. (RGNX)
Board Member

Proxy statement

Current
2009-01-01–present
REGENXBIO Inc. (RGNX)
CEO

Source not stated

Start not stated–2024-07-01

Company network

Recorded roles and call appearances connecting this person to public companies.

REGENXBIO Inc.

RGNX

Current role

Board Member

2009-01-01–present

1 appearance Latest appearance 2026-09-15

View calls and events

Leadership on record at REGENXBIO Inc.

Other people whose current roles at this company are on record from its filings.

Curran M. Simpson CEO, COO, Board Member
Allan M. Fox Chairman, Board Member
Kenneth T. Mills Chairman, Board Member
Former EVP CFO
Mitchell Chan Chief Accounting Officer
Alexandra Glucksmann Board Member
Alexandra Glucksmann, Ph.D. Board Member
Curran Simpson Board Member
Daniel Tassé Board Member
David Stump Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	REGENXBIO Inc. (RGNX)	Former President and CEO	$340,998	—	$1,175,649	$3,489,594	$406,074	$94,723	$5,507,038
2023	REGENXBIO Inc. (RGNX)	Former President and CEO	$676,790	—	$1,218,254	$3,698,138	$304,555	$18,975	$5,916,713
2022	REGENXBIO Inc. (RGNX)	Former President and CEO	$650,759	—	$1,228,161	$3,505,846	$351,410	$17,538	$5,753,713
2021	REGENXBIO Inc. (RGNX)	President and CEO	$631,805	$600,000	$1,843,050	$5,057,556	$473,854	$16,675	$8,622,941
2020	REGENXBIO Inc. (RGNX)	President and CEO	$613,403	—	—	$6,646,254	$368,042	$16,388	$7,644,087
2019	REGENXBIO Inc. (RGNX)	President and CEO	$595,537	—	—	$5,160,444	$375,188	$16,100	$6,147,269
2018	REGENXBIO Inc. (RGNX)	President and CEO	$546,364	—	—	$3,895,222	$480,800	$15,813	$4,938,199

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Conference Baird 2026 Global Healthcare Conference REGENXBIO Inc. (RGNX)
2026-09-15
Executive change Resigned: President and Chief Executive Officer REGENXBIO Inc. (RGNX)
2024-07-01